Provided by Tiger Fintech (Singapore) Pte. Ltd.

Viking Therapeutics

30.70
-0.9300-2.94%
Pre-market: 30.810.1100+0.36%08:42 EDT
Volume:2.46M
Turnover:76.22M
Market Cap:3.45B
PE:-26.62
High:31.75
Open:31.75
Low:30.60
Close:31.63
Loading ...

Why Viking Therapeutics, Inc. (VKTX) Soared on Tuesday

Insider Monkey
·
06 Mar

Novo Nordisk Plunges 21% in 3 Months: Buy, Sell or Hold the Stock?

Zacks
·
05 Mar

Viking Therapeutics to Participate at Upcoming Investor Conferences

PR Newswire
·
05 Mar

Viking Therapeutics (NasdaqCM:VKTX) Reports US$35M Q4 Loss As Stock Falls 12%

Simply Wall St.
·
05 Mar

Viking Therapeutics call volume above normal and directionally bullish

TIPRANKS
·
04 Mar

AbbVie Enters The Obesity Arena. Why It's Paying Up To $2.23 Billion.

Blockhead
·
03 Mar

ABBV Enters Obesity Bandwagon, Inks $2.2B Licensing Deal for Amylin Drug

Zacks
·
03 Mar

Viking Therapeutics, Inc. (VKTX) Ascends But Remains Behind Market: Some Facts to Note

Zacks
·
01 Mar

Is Viking Therapeutics, Inc. (VKTX) the Worst Performing Mid Cap Stock to Buy According to Analysts?

Insider Monkey
·
01 Mar

Viking Therapeutics, Inc. (VKTX): A Bull Case Theory

Insider Monkey
·
27 Feb

Is Viking Therapeutics a Buy Right Now?

Motley Fool
·
26 Feb

Why this newly public biotech could become a force in obesity treatments

Dow Jones
·
26 Feb

Perrigo Gears Up to Report Q4 Earnings: Here's What to Expect

Zacks
·
25 Feb

Viking Therapeutics (VKTX): Among the Oversold Biotech Stocks to Buy Now

Insider Monkey
·
25 Feb

Should You Buy VKTX Stock Amid Renewed M&A Speculations?

Zacks
·
24 Feb

Citi Reaffirms Their Hold Rating on Viking Therapeutics (VKTX)

TIPRANKS
·
24 Feb

Truist Financial Remains a Buy on Viking Therapeutics (VKTX)

TIPRANKS
·
24 Feb

Why Viking Therapeutics Inc. (VKTX) Surged On Friday?

Insider Monkey
·
22 Feb

Viking Therapeutics call volume above normal and directionally bullish

TIPRANKS
·
22 Feb

Viking Therapeutics rumor highlighted in Betaville alert

TIPRANKS
·
22 Feb